Intellus Worldwide 2024
A shoutout to the Intellus Worldwide Institute for an exciting lineup of topics at this year’s conference, covering critical areas such as the use of technology and data for deeper insights and patient engagement! These are more than just trends—they are shaping the future of life sciences and patient outcomes. At Clinakos Inc., we’re fully […]
Advantages of Clinakos’ Approach For Commercial
The McKinsey Global Institute (MGI) estimates that AI technologies could generate between $60 billion and $110 billion annually for the pharmaceutical and medical-product industries. At Clinakos Inc., we harness the power of Integrated Patient Data™ and Medically Smart AI™ to deliver real-time insights that drive smarter, faster decisions in life sciences. Our platform builds 360-degree […]
Breaking Barriers in Rare Disease Research with Clinakos
According to the National Organization for Rare Disorders (NORD), over 7,000 rare diseases impact millions of patients, yet fewer than 500 have FDA-approved treatments. For patients living with rare diseases, the journey to a diagnosis is often long and difficult, with many facing misdiagnoses or remaining undiagnosed for years. At Clinakos Inc., we’re dedicated to […]
Driving Better Patient Outcomes in Cancer Research
In 2023, nearly 1.9 million new cancer cases were diagnosed in the U.S., with over 600,000 lives lost, according to the American Cancer Society. These numbers serve as a stark reminder of the urgent need for breakthroughs in oncology research and cancer treatment. At Clinakos Inc., we are at the forefront of this fight. Our […]
Exploring the New Frontiers in Real-World Evidence
The FDA‘s recent guidance on using real-world evidence (RWE) in observational research has opened new pathways for innovation in healthcare research. As we embrace these changes, it’s crucial to consider how we can further enhance the utility of #RWE. Here are three pivotal areas where expanded FDA guidance could significantly impact the future of healthcare […]
Transforming Lifesciences with NLP
According to Gramener, a Gartner-recognized company, Natural Language Processing (NLP) is projected to add $4.3 billion in revenue to the healthcare market by 2026. Clinakos Inc.‘s Medically Smart AI™ leverages NLP and Machine Learning (ML) to ignite innovation and improve patient outcomes. Our AI-driven insights are backed by advanced data science techniques, refined on vast […]
Transforming Healthcare with Patient360
Clinakos’ Integrated Patient Data is linked and curated from thousands of data sources from EHRs, lab results, imaging reports, SDOH, and patient-reported outcomes. This integrated approach enables a holistic Patient360 view of the patients to understand the full scope of a patient’s medical history, leading to more informed decisions and personalized care. With an integrated […]
Transforming Patient Outcomes
Did you know that the UK pays up to £30,000 per QALY (Quality Adjusted Life Year) for drugs used by their patients. In the US, organizations like ICER may evaluate the value of life-saving drugs, and the reimbursements can be even higher. Organizations like ISPOR—The Professional Society for Health Economics and Outcomes Research and Medical […]
Stanford University and US DOJ’s “The Promoting Competition in AI” Event
Thank you Stanford University and US DOJ for inviting me to join the “The Promoting Competition in AI” event co-hosted by the U.S. Department of Justice and the Stanford Institute for Economic Policy Research, yesterday, May 30th. Event speakers & attendees included top US, European and UK governmental agency heads; DOJ, US PTO, CMS & […]
ISPOR24 Was Wrapped up with Many Invaluable Insights
ISPOR24 came to a completion yesterday and completely lived up to its reputation of being the top global event for Health Economics and Outcomes Research (HEOR) professionals. The event started with the first of its kind workshop focused “Patient-Centered Research Summit 2024”. Clinakos Inc. attended with other attendees from key institutions like FDA and PCORI, […]
